We are delighted to announce a number of new research awards that have been made to researchers at the Institute of Ophthalmology. Congratulations to the staff who have won funding and thank you to the bodies who fund our work. Together we are making a difference. A full list of awards is shown below:
| Researcher | Funder | Project title | IoO Amount |
| Robin Ali | Macular Society | Purchase of a bioreactor cell culture platform to support our photoreceptor differentiation for the treatment and modelling of retinal degenerations. | £13,613 |
| Maryse Bailly | Rosetrees Trust | The protein as LIMCH1 as novel disease marker in fibrosis and cancer | £20,217 |
| Maryse Bailly | Moorfields Eye Charity | The role of Src family kinases in Thyroid Eye Disease: disease mechanisms and therapeutic potential | £49,000 |
| Virginia Calder | Ziarco Pharma Ltd | Validation of H4R directed inhibition in EAU model | £ 33,115 |
| Matteo Carandini (fellow: Nick Steinmetz) | EU H2020 | Neocortical circuits underlying visually-guided behaviour in mouse | £126,576 |
| Matteo Carandini (fellow: Andrew Peters) | Royal Society | Corticostriatal interactions in perceptual learning | £101,000 |
| Matteo Carandini (fellow: Julien Fournier) | EU Marie Curie | Vision and Navigation in Mouse Cortex | £ 136,818 |
| Francesca Cordeiro | Wellcome Trust | Topical delivery of Ranibizumab (Lucentis) for non-invasive treatment of retinal disease | £1,666,193 |
| Julie Daniels | Animal Health Trust | Deriving an in vitro source of canine corneal stromal cells to use as a tool to study inherited dystrophies in dogs | £88,500 |
| Alex Day | NIHR | A Randomised Comparison of Femtosecond Laser Assisted vs Manual Phacoemulsification Cataract Surgery for Adults with Visually Significant Cataract: The FACT trial | £54,958 |
| Clare Futter | Wellcome Trust | Cell biology and pathology of the retinal pigment epithelium | £87,155 |
| Peng Khaw | Moorfields Eye Charity | Identification of novel biomarkers to develop a customised gene chip in conjunctival fibrosis | £6,710 |
| Sue Lightman | National Institutes of Health (US) | Macular Edema Trials Associated with MUST (META-MUST): POINT and MERIT | £80,755 |
| Sue Lightman | NIHR | Optimal utilisation of biologic drugs in Behçet’s Disease | £12,961 |
| John Marshall | Moorfields Eye Charity | Final laser-dose titration data required to enable re-instatement of clinical trials for the 2RT-mediated laser treatment of dry AMD. | £46,530 |
| Mike Michaelides | National Institutes of Health (US) | Platform Technologies for Microscopic Retinal Imaging: Development & Translation | £20,549 |
| Mariya Moosajee | NIHR BRC | Mapping the clinical phenotype of Choroideremia to identify an optimal therapeutic window for preventing sight loss- A UK multicentre deep phenotyping study | £182,121 |
| Shin-ichi Ohnuma | Moorfields Eye Charity | Unlocking the genetic code – Single cell separator | £160,600 |
| Christiana Ruhrberg | MRC | Defining a novel molecular mechanism in VEGF-induced vascular hyperpermeability | £564,176 |
| Christiana Ruhrberg | British Heart Foundation | BHF Studentship rotation for Kirsty Naylor | £2,250 |
| Christiana Ruhrberg | British Heart Foundation | BHF student rotation for Rebecca Bolton | £2,250 |
| Mandeep Sagoo | Royal College of Surgeons Edinburgh | Identification of new mechanisms and targets in retinoblastoma | £49,985 |
| Yu Wai Man, Patrick | NIHR BRC | Rare diseases project in dominant optic atrophy | £154,856 |
| Patrick Yu Wai Man | Moorfields Eye Charity | Investigating disease mechanisms in autosomal dominant optic atrophy with retinal ganglion cells derived from induced pluripotent stem cells | £109,914 |